1. Jain R, Gopal A, Pathak BK, et al. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio and Their Role as Predictors of Disease Severity of Coronavirus Disease 2019 (COVID-19). J Lab Physicians. 2021;13(1):58-63.
2. Mohammadshahi J, Ghobadi H, Matinfar G, et al. Role of Lipid Profile and Its Relative Ratios (Cholesterol/HDL-C, Triglyceride/HDL-C, LDL-C/HDL-C, WBC/HDL-C, and FBG/HDL-C) on Admission Predicts In-Hospital Mortality COVID-19. J Lipids. 2023;2023:6329873.
3. Shahla F, Faranak S, Shahram H, et al. Laboratory and clinical findings in hospitalized pregnant women with Covid-19 based on disease outcome during the outbreak of Delta variant in Ardabil (summer and autumn 2021). Iranina J Obstetrics Gynecol Infertility. 2022;25(9):29-39.
4. García-Menaya JM, Cordobés-Durán C, Rangel-Mayoral JF, et al. Outcomes and Laboratory and Clinical Findings of Asthma and Allergic Patients Admitted With Covid-19 in a Spanish University Hospital. Front pharmacol. 2020;11:570721.
5. Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95(7):834-7.
6. Henry BM, de Oliveira MHS, Benoit S, et al. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020; 58(7):1021-8.
7. Chan AS, Rout A. Use of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19. J Clin Med Res. 2020;12(7):448-53.
8. Yang AP, Liu JP, Tao WQ, et al. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. 2020; 84:106504.
9. Shang W, Dong J, Ren Y, et al. The value of clinical parameters in predicting the severity of COVID-19. J Med Virol. 2020;92(10):2188-92.
10. Hosseninia S, Ghobadi H, Garjani K, et al. Aggregate index of systemic inflammation (AISI) in admission as a reliable predictor of mortality in COPD patients with COVID-19. BMC Pulmonary Med. 2023;23(1):107.
11. Ghobadi H, Mohammadshahi J, Javaheri N, et al. Role of leukocytes and systemic inflammation indexes (NLR, PLR, MLP, dNLR, NLPR, AISI, SIR-I, and SII) on admission predicts in-hospital mortality in non-elderly and elderly COVID-19 patients. Front Med (Lausanne). 2022;9:916453.
12. Kim SH, Ji E, Won SH, et al. Association of asthma comorbidity with poor prognosis of coronavirus disease 2019. World Allergy Organ J. 2021; 14(8):100576.
13. Gao YD, Agache I, Akdis M, et al. The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19. Int Immunol. 2022;34(4):177-88.
14. Lemus Calderon JA, Beneyto Martin P, Guzmán Rodriguez R, et al. Differentiating characteristics of patients with asthma in the severe acute respiratory syndrome coronavirus 2 infection. Ann Allergy Asthma Immunol. 2021;126(1):92-3.
15. Lee SC, Son KJ, Han CH, et al. Impact of comorbid asthma on severity of coronavirus disease (COVID-19). Sci Rep. 2020;10(1):21805.
16. Paliogiannis P, Zinellu A, Scano V, et al. Laboratory test alterations in patients with COVID-19 and non COVID-19 interstitial pneumonia: a preliminary report. J Infect Dev Ctries. 2020;14(7):685-90.
17. Tjendra Y, Al Mana AF, Espejo AP, et al. Predicting Disease Severity and Outcome in COVID-19 Patients: A Review of Multiple Biomarkers. Arch Pathol Lab Med. 2020;144(12):1465-74.
18. Waris A, Din M, Khalid A, et al. Evaluation of hematological parameters as an indicator of disease severity in Covid-19 patients: Pakistan’s experience. J Clin Lab Anal. 2021;35(6):e23809.
19. Gerotziafas GT, Sergentanis TN, Voiriot G, et al. Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19. Thromb Haemost. 2020;120(12):1680-90.
20. Fois AG, Paliogiannis P, Scano V, Cau s, Babudieri S, Perra R, et al. The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients. Molecules. 2020; 25(23):5725.
21. Veras FP, Pontelli MC, Silva CM, Toller-Kawahisa GE, de Lima M, Carvalho Nascimento D, et al. SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. J Exp Med. 2020; 217(12): e20201129.
22. Tomar B, Anders HJ, Desai J, Mulay SR. Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19. Cells.2020; 9(6):1383.
23. Urbanowicz T, Michalak M, Olasińska-Wiśniewska A, Rodzki M, Witkowska A, Gąsecka A, et al. Neutrophil counts, neutrophil-to-lymphocyte ratio, and Systemic Inflammatory Response Index (SIRI) predict mortality after off-pump coronary artery bypass surgery. Cells. 2022;11(7):1124.
24. Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Lek Listy. 2021;122(7):474-88.
25. Urbanowicz T, Michalak M, Gąsecka A, et al. Postoperative Neutrophil to Lymphocyte Ratio as an Overall Mortality Midterm Prognostic Factor following OPCAB Procedures. Clin Practice. 2021;11(3):587-597.
26. Aly MM, Meshref TS, Abdelhameid MA, et al. Can hematological ratios predict outcome of COVID-19 patients? A multicentric study. J Blood Med. 2021:505-15.
27. Eissa M, Shaarawy S, Abdellateif MS. The role of different inflammatory indices in the diagnosis of COVID-19. Inte J General Med. 2021:7843-7853.
28. Ertekin B, Yortanlı M, Özelbaykal O, et al. The Relationship between Routine Blood Parameters and the Prognosis of COVID-19 Patients in the Emergency Department. Emergency Med Int. 2021;2021.
29. Citu C, Gorun F, Motoc A, et al. The predictive role of NLR, d-NLR, MLR, and SIRI in COVID-19 mortality. Diagnostics. 2022;12(1):122.
30. Simadibrata DM, Pandhita BAW, Ananta ME, et al. Platelet-to-lymphocyte ratio, a novel biomarker to predict the severity of COVID-19 patients: A systematic review and meta-analysis. Journal of the intensive Care Society. 2022;23(1):20-6.
31. Zhang Y, Xing Z, Zhou K, et al. The predictive role of systemic inflammation response index (SIRI) in the prognosis of stroke patients. Clinical interventions in aging. 2021:1997-2007.
32. Kim J-W, Jung J-Y, Suh C-H, et al. Systemic immune-inflammation index combined with ferritin can serve as a reliable assessment score for adult-onset Still’s disease. Clin Rheumatol. 2021;40:661-8.